Condition
Hepatocarcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Hepatocarcinoma clinical trials that are recruiting, at sites in 4 countries (most in Italy (3), China (1), Germany (1)). By phase: Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 4Countries
Newest Hepatocarcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Testing microRNA and serum markers in early liver cancer patients treated with thermoablation | — | Bologna, Emilia-Romagna | Recruiting | May 22, 2026 |
| Mapping epigenetic changes that help liver cancer evade the immune system using detailed molecular profiling. | — | Milan, Lombardy | Recruiting | Feb 25, 2026 |
| Skin tests to check biotherapy allergies in cancer patients | — | Angers | Recruiting | May 14, 2025 |
| Predicting liver disease complications and cancer development in patients | — | Münster, North Rhine-Westphalia | Recruiting | Jul 26, 2024 |
| Evaluating mutations in solid tumors using liquid biopsy and genome sequencing | — | Aviano, Pordonone | Recruiting | Sep 8, 2023 |
| Infusion of checkpoint inhibitors and chemotherapy for advanced solid tumors | Phase 2/3 | Guanzhou, Guangdong | Recruiting | Nov 28, 2018 |
All recruiting trials (6)
-
Testing microRNA and serum markers in early liver cancer patients treated with thermoablation
We are seeing if certain microRNAs and serum metabolites can predict how well patients with early hepatocellular carcinoma respond to thermoablation.
-
Mapping epigenetic changes that help liver cancer evade the immune system using detailed molecular profiling.
This project will use tumor and blood samples from people with hepatocellular carcinoma to see if specific noncoding RNAs and epigenetic changes are linked to T cell dysfunction in tumors.
-
Skin tests to check biotherapy allergies in cancer patients
We are testing skin tests to see if cancer patients treated with biotherapies have allergies or hypersensitivity to those drugs.
-
Predicting liver disease complications and cancer development in patients
This study is testing if a new way of monitoring patients with advanced liver disease can help predict serious health issues and cancer better than standard care.
-
Evaluating mutations in solid tumors using liquid biopsy and genome sequencing
This study is trying to see if a blood test can find important gene changes in patients with advanced solid tumors to help doctors choose the best treatments for them.
-
Infusion of checkpoint inhibitors and chemotherapy for advanced solid tumors
This study is testing if giving a mix of immune therapy and chemotherapy directly to tumors helps people with advanced cancers feel better compared to the usual way of giving these treatments.
Related topics
Quick answers
How many Hepatocarcinoma clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Italy (3 trials), China (1 trial), Germany (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.